Search Results - "Statsyuk, Alexander V."

Refine Results
  1. 1

    Development of Activity-Based Probes for Ubiquitin and Ubiquitin-like Protein Signaling Pathways by An, Heeseon, Statsyuk, Alexander V

    Published in Journal of the American Chemical Society (13-11-2013)
    “…Ubiquitin and ubiquitin-like (UBL) proteins regulate a vast variety of cellular functions. Some UBL proteins are present in all cell types, while others are…”
    Get full text
    Journal Article
  2. 2

    An inhibitor of ubiquitin conjugation and aggresome formation by An, Heeseon, Statsyuk, Alexander V

    Published in Chemical science (Cambridge) (01-01-2015)
    “…Proteasome inhibitors have revolutionized the treatment of multiple myeloma, and validated the therapeutic potential of the ubiquitin proteasome system (UPS)…”
    Get full text
    Journal Article
  3. 3

    Dissecting the Specificity of Adenosyl Sulfamate Inhibitors Targeting the Ubiquitin-Activating Enzyme by Misra, Mohit, Kuhn, Maximilian, Löbel, Mark, An, Heeseon, Statsyuk, Alexander V., Sotriffer, Christoph, Schindelin, Hermann

    Published in Structure (London) (05-07-2017)
    “…Targeting the activating enzymes (E1) of ubiquitin (Ub) and ubiquitin-like modifiers (Ubls) has emerged as a promising anti-cancer strategy, possibly…”
    Get full text
    Journal Article
  4. 4

    Catalytically Important Residues of E6AP Ubiquitin Ligase Identified Using Acid-Cleavable Photo-Cross-Linkers by Krist, David T, Statsyuk, Alexander V

    Published in Biochemistry (Easton) (28-07-2015)
    “…Inactivation of the E6AP E3 ubiquitin ligase (UBE3A gene) causes Angelman syndrome, while aberrant degradation of p53 by E6AP is implicated in cervical…”
    Get full text
    Journal Article
  5. 5

    Inhibiting protein synthesis to treat malaria by Statsyuk, Alexander V

    “…Covalent prodrugs inhibit protein synthesis targets killing parasites but not human cells…”
    Get full text
    Journal Article
  6. 6

    A Fragment-Based Method to Discover Irreversible Covalent Inhibitors of Cysteine Proteases by Kathman, Stefan G, Xu, Ziyang, Statsyuk, Alexander V

    Published in Journal of medicinal chemistry (12-06-2014)
    “…A novel fragment-based drug discovery approach is reported which irreversibly tethers drug-like fragments to catalytic cysteines. We attached an electrophile…”
    Get full text
    Journal Article
  7. 7

    Let K-Ras activate its own inhibitor by Statsyuk, Alexander V.

    Published in Nature structural & molecular biology (01-06-2018)
    “…Traditional approaches to covalent drug design postulate that noncovalent binding affinity ( K i ) should be in the nanomolar range for the lead compound to be…”
    Get full text
    Journal Article
  8. 8

    Facile synthesis of covalent probes to capture enzymatic intermediates during E1 enzyme catalysis by An, Heeseon, Statsyuk, Alexander V

    “…We report a facile synthetic strategy to prepare UBL-AMP electrophilic probes that form a covalent bond with the catalytic cysteine of cognate E1s, mimicking…”
    Get more information
    Journal Article
  9. 9

    A Small Molecule That Switches a Ubiquitin Ligase From a Processive to a Distributive Enzymatic Mechanism by Kathman, Stefan G, Span, Ingrid, Smith, Aaron T, Xu, Ziyang, Zhan, Jennifer, Rosenzweig, Amy C, Statsyuk, Alexander V

    Published in Journal of the American Chemical Society (07-10-2015)
    “…E3 ligases are genetically implicated in many human diseases, yet E3 enzyme mechanisms are not fully understood, and there is a strong need for pharmacological…”
    Get full text
    Journal Article
  10. 10

    UbMES and UbFluor: Novel probes for ring-between-ring (RBR) E3 ubiquitin ligase PARKIN by Park, Sungjin, Foote, Peter K., Krist, David T., Rice, Sarah E., Statsyuk, Alexander V.

    Published in The Journal of biological chemistry (06-10-2017)
    “…Ring-between-ring (RBR) E3 ligases have been implicated in autoimmune disorders and neurodegenerative diseases. The functions of many RBR E3s are poorly…”
    Get full text
    Journal Article
  11. 11

    Mapping low-affinity/high-specificity peptide–protein interactions using ligand-footprinting mass spectrometry by Parker, Benjamin W., Goncz, Edward J., Krist, David T., Statsyuk, Alexander V., Nesvizhskii, Alexey I., Weiss, Eric L.

    “…Short linear peptide motifs that are intracellular ligands of folded proteins are a modular, incompletely understood molecular interaction language in…”
    Get full text
    Journal Article
  12. 12

    Covalent-Fragment Screening of BRD4 Identifies a Ligandable Site Orthogonal to the Acetyl-Lysine Binding Sites by Olp, Michael D, Sprague, Daniel J, Goetz, Christopher J, Kathman, Stefan G, Wynia-Smith, Sarah L, Shishodia, Shifali, Summers, Steven B, Xu, Ziyang, Statsyuk, Alexander V, Smith, Brian C

    Published in ACS chemical biology (17-04-2020)
    “…BRD4, a member of the bromodomain and extraterminal domain (BET) family, has emerged as a promising epigenetic target in cancer and inflammatory disorders. All…”
    Get full text
    Journal Article
  13. 13

    Protein ubiquitination and formation of polyubiquitin chains without ATP, E1 and E2 enzymes by Park, Sungjin, Krist, David T, Statsyuk, Alexander V

    Published in Chemical science (Cambridge) (01-03-2015)
    “…Studying protein ubiquitination is difficult due to the complexity of the E1-E2-E3 ubiquitination cascade. Here we report the discovery that C-terminal…”
    Get full text
    Journal Article
  14. 14

    Discovery of covalent enzyme inhibitors using virtual docking of covalent fragments by Chowdhury, Sandipan Roy, Kennedy, Steven, Zhu, Kai, Mishra, Rama, Chuong, Patrick, Nguyen, Alyssa-uyen, Kathman, Stefan G., Statsyuk, Alexander V.

    Published in Bioorganic & medicinal chemistry letters (01-01-2019)
    “…[Display omitted] •Virtual docking of 1648 covalent fragments is performed.•Covalent inhibitor of Cathepsin L is identified.•Cathepsin L inhibitor did not…”
    Get full text
    Journal Article
  15. 15

    Structural Basis of Substrate Recognition and Covalent Inhibition of Cdu1 from Chlamydia trachomatis by Ramirez, Yesid A., Adler, Thomas B., Altmann, Eva, Klemm, Theresa, Tiesmeyer, Christian, Sauer, Florian, Kathman, Stefan G., Statsyuk, Alexander V., Sotriffer, Christoph, Kisker, Caroline

    Published in ChemMedChem (08-10-2018)
    “…Based on the similarity between the active sites of the deubiquitylating and deneddylating enzyme ChlaDub1 (Cdu1) and the evolutionarily related protease…”
    Get full text
    Journal Article
  16. 16

    UbFluor: A Mechanism-Based Probe for HECT E3 Ligases by Krist, David T, Park, Sungjin, Boneh, Galyah H, Rice, Sarah E, Statsyuk, Alexander V

    Published in Chemical science (Cambridge) (01-01-2016)
    “…Homologous to E6AP Carboxyl Terminus E3 ubiquitin ligases (HECT, ~28 known) are genetically implicated in cancer, neurological, hypertensive, and autoimmune…”
    Get full text
    Journal Article
  17. 17

    The development of a one pot, regiocontrolled, three-component reaction for the synthesis of thieno[2,3-c]pyrroles by Hong, Cynthia M, Statsyuk, Alexander V

    Published in Organic & biomolecular chemistry (14-05-2013)
    “…A three-component reaction has been developed that allows the regioselective synthesis of thieno[2,3-c]pyrroles. The reaction is based on the ability of…”
    Get more information
    Journal Article
  18. 18

    Crosstalk between kinases and Nedd4 family ubiquitin ligases by An, Heeseon, Krist, David T, Statsyuk, Alexander V

    Published in Molecular bioSystems (01-01-2014)
    “…A dazzling array of human biological processes achieves coordination and balance through the posttranslational modification of protein residues with phosphate…”
    Get more information
    Journal Article
  19. 19

    High-Throughput Screening of HECT E3 Ubiquitin Ligases Using UbFluor by Foote, Peter K, Krist, David T, Statsyuk, Alexander V

    Published in Current protocols in chemical biology (14-09-2017)
    “…HECT E3 ubiquitin ligases are responsible for many human disease phenotypes and are promising drug targets; however, screening assays for HECT E3 inhibitors…”
    Get more information
    Journal Article
  20. 20

    An inhibitor of ubiquitin conjugation and aggresome formationElectronic supplementary information (ESI) available. See DOI: 10.1039/c5sc01351h by An, Heeseon, Statsyuk, Alexander V

    Published 10-08-2015
    “…Proteasome inhibitors have revolutionized the treatment of multiple myeloma, and validated the therapeutic potential of the ubiquitin proteasome system (UPS)…”
    Get full text
    Journal Article